文献速递神经儿科影像MR

哌甲酯对注意缺陷多动障碍儿童和成人皮质厚度的影响:一项随机临床试验

Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-01-01

该随机双盲安慰剂对照试验纳入99名男性注意缺陷多动障碍患者(10-12岁儿童或23-40岁成人),随机接受哌甲酯或安慰剂治疗16周,用MR成像评估预设ROI皮质厚度变化。结果显示右侧内侧皮质ROI存在时间×药物×年龄交互作用(F[1,88.825]=4.316,P<.05),哌甲酯使儿童皮质变薄减少,而成人或安慰剂组无此表现。作者认为该药可能影响该脑区灰质发育,需在更大样本和更长随访中重复验证。

要点

  • 哌甲酯治疗16周后,儿童右侧内侧皮质ROI变薄程度小于成人及安慰剂组。
  • 右侧内侧皮质ROI存在时间×药物×年龄交互作用(F[1,88.825]=4.316,P<.05)。
  • 作者认为该药可能影响该脑区灰质发育,需更大样本和更长随访重复验证。

关键影像表现/征象

  • 右侧内侧皮质ROI存在时间×药物×年龄交互作用(F[1,88.825]=4.316,P<.05)。
  • 哌甲酯治疗使儿童皮质变薄减少,但成人或安慰剂组未见此表现。

局限性

  • 作者结论指出需在更大样本和更长随访中重复验证,以确定该效应是否见于其他皮质脑区及是否有长期后果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Although methylphenidate is frequently used to treat children with attention-deficit/hyperactivity disorder, it is currently unknown how methylphenidate affects brain development. In a randomized controlled trial, we investigated whether the cortical effects of methylphenidate are modulated by age.

MATERIALS AND METHODS: Between June 1, 2011, and June 15, 2015, we conducted a randomized, double-blind, placebo-controlled trial (Effects of Psychotropic Drugs on Developing Brain-Methylphenidate) in 99 males with attention-deficit/hyperactivity disorder (according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, criteria) from referral centers in the greater Amsterdam area in the Netherlands. The trial was registered on March 24, 2011 (identifier NL34509.000.10) and subsequently at the Netherlands National Trial Register (identifier NTR3103). Participants (first enrolled October 13, 2011) were 10-12 years or 23-40 years of age and randomized to treatment with either methylphenidate or a placebo for 16 weeks. Our main outcome was a change in cortical thickness in predefined ROIs as measured by MR imaging pre- and posttreatment.

RESULTS: We observed a time × medication × age interaction (F[1,88.825] = 4.316, P < .05) for the right medial cortex ROI, where methylphenidate treatment yielded less cortical thinning in children, but not in adults or the placebo groups.

CONCLUSIONS: Our finding that the effects of methylphenidate on right medial cortical thickness differ between children and adults infers that the drug affects gray matter development in this brain region. This warrants replication in larger groups with longer follow-up to determine whether this effect can also be observed in other cortical brain regions and whether it may have long-term consequences.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Walhovd KB, Amlien I, Schrantee A, et al. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. AJNR Am J Neuroradiol. 2020. PMID: 32414901. doi:10.3174/ajnr.A6560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。